D Liu

机构：BGI Group (China), Shandong Tumor Hospital, Shandong Provincial QianFoShan Hospital, Shandong First Medical University

发表论文 11 篇 · 总被引 83 次 · h-index 3

代表论文

• Quorum Sensing: Not Just a Bridge Between Bacteria (2025 · MicrobiologyOpen · 被引 42)
• Prodigiosin: unveiling the crimson wonder – a comprehensive journey from diverse bioactivity to synthesis and yield enhancement (2024 · Frontiers in Microbiology · 被引 27)
• [Swertiamarin alleviates diabetic peripheral neuropathy in rats by suppressing NOXS/ ROS/NLRP3 signal pathway]. (2021 · PubMed · 被引 8)
• Research Progress of Microneedles in Vaccine Delivery (2025 · Current Medicinal Chemistry · 被引 3)
• [Association between volatile organic compounds and mortality risk of stroke]. (2023 · PubMed · 被引 2)
• [Fibroblasts overpressing WNT2b cause impairment of intestinal mucosal barrier]. (2023 · PubMed · 被引 1)